Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-May-24 4:35 PM View:  | Amron Arthur H Director | Nephros Inc. (NEPH) | 30-May-24 | Purchase | 3,000 | $2.24 | $6,734.70 | 3% 100.46K to 103.46K | |
| 30-May-24 4:35 PM View: | Amron Arthur H Director | Nephros Inc. (NEPH) | 28-May-24 | Private Purchase | 2,000 | $2.22 | $4,441.40 | 2% 98.46K to 100.46K | |
| 16-May-24 4:49 PM View: | Banks Robert R. Jr. President and CEO Director | Nephros Inc. (NEPH) | 16-May-24 | Private Purchase | 50,000 | $2.24 | $112,050.00 | 250% 20.0K to 70.0K | |
| 14-Mar-24 4:43 PM View: | Wexford Capital LLC 10% Owner | Nephros Inc. (NEPH) | 13-Mar-24 | Disposition (other) | 91,463 | -- | -- | (2%) 3.69M to 3.6M | |
| 14-Mar-24 4:28 PM View: | Amron Arthur H Director | Nephros Inc. (NEPH) | 13-Mar-24 | Acquisition (other) | 91,463 | -- | -- | 1307% 7.0K to 98.46K | |
| 14-Mar-24 4:28 PM View: | Amron Arthur H Director | Nephros Inc. (NEPH) | 12-Mar-24 | Private Purchase | 7,000 | $2.45 | $17,129.70 | 100% 0 to 7.0K | |
| 15-Dec-23 4:48 PM View: | Spandow Oliver J. Director | Nephros Inc. (NEPH) | 13-Dec-23 | Grant | 14,294 | -- | -- | 21% 67.31K to 81.6K | |
| 15-Dec-23 4:47 PM View: | Amron Arthur H Director | Nephros Inc. (NEPH) | 13-Dec-23 | Grant | 9,291 | -- | -- | 100% 0 to 9.29K | |
| 15-Dec-23 4:48 PM View: | Lask Alisa Director | Nephros Inc. (NEPH) | 13-Dec-23 | Grant | 9,291 | -- | -- | 24% 39.34K to 48.63K | |
| 15-Dec-23 4:48 PM View: | Harris Joseph Michael Director | Nephros Inc. (NEPH) | 13-Dec-23 | Grant | 9,291 | -- | -- | 111% 8.4K to 17.69K | |
| 11-Dec-23 4:17 PM View: | Banks Robert R. Jr. President and CEO Director | Nephros Inc. (NEPH) | 07-Dec-23 | Private Purchase | 18,000 | $2.20 | $39,646.80 | 900% 2.0K to 20.0K | |
| 15-Aug-23 4:15 PM View: | Banks Robert R. Jr. President and CEO Director | Nephros Inc. (NEPH) | 15-Aug-23 | Purchase | 1,901 | $1.69 | $3,206.80 | 1920% 99 to 2.0K | |
| 15-Aug-23 4:15 PM View: | Banks Robert R. Jr. President and CEO Director | Nephros Inc. (NEPH) | 14-Aug-23 | Private Purchase | 99 | $1.50 | $148.50 | 100% 0 to 99 | |
| 09-Jan-23 4:33 PM View: | Lask Alisa Director | Nephros Inc. (NEPH) | 05-Jan-23 | Grant | 27,613 | -- | -- | 236% 11.72K to 39.34K | |
| 09-Jan-23 4:31 PM View: | Gwydir Tom Director | Nephros Inc. (NEPH) | 05-Jan-23 | Grant | 27,613 | -- | -- | 177% 15.61K to 43.23K | |
| 09-Jan-23 4:30 PM View: | Harris Joseph Michael Director | Nephros Inc. (NEPH) | 05-Jan-23 | Grant | 8,402 | -- | -- | 100% 0 to 8.4K | |
| 09-Jan-23 4:32 PM View: | Spandow Oliver J. Director | Nephros Inc. (NEPH) | 05-Jan-23 | Grant | 42,481 | -- | -- | 171% 24.83K to 67.31K | |
| 09-Jan-23 4:31 PM View: | Amron Arthur H Director | Nephros Inc. (NEPH) | 05-Jan-23 | Grant | 27,613 | -- | -- | 100% 0 to 27.61K | |
| 07-Mar-22 5:44 PM View: | Astor Andrew President, CEO & CFO Director | Nephros Inc. (NEPH) | 05-Mar-22 | Option Exercise | 14,815 | $2.70 | $40,000.50 | 19% 77.96K to 92.77K | |
| 18-Feb-22 5:03 PM View: | Lobo Wesley S. Chief Marketing Officer | Nephros Inc. (NEPH) | 16-Feb-22 | Payment of Exercise | 6,389 | $4.80 | $30,667.20 | (15%) 41.56K to 35.17K | |
| 16-Dec-21 9:17 PM View: | Lask Alisa Director | Nephros Inc. (NEPH) | 14-Dec-21 | Grant | 4,582 | -- | -- | 64% 7.14K to 11.72K | |
| 16-Dec-21 9:16 PM View: | Amron Arthur H Director | Nephros Inc. (NEPH) | 14-Dec-21 | Grant | 4,582 | -- | -- | 100% 0 to 4.58K | |
| 16-Dec-21 9:17 PM View: | Gwydir Tom Director | Nephros Inc. (NEPH) | 14-Dec-21 | Grant | 4,582 | -- | -- | 42% 11.03K to 15.61K | |
| 16-Dec-21 9:16 PM View: | Spandow Oliver J. Director | Nephros Inc. (NEPH) | 14-Dec-21 | Grant | 5,429 | -- | -- | 28% 19.4K to 24.83K | |
| 23-Aug-21 1:01 PM View: | Lobo Wesley S. Chief Marketing Officer | Nephros Inc. (NEPH) | 20-Aug-21 | Market Purchase | 1,000 | $7.92 | $7,920.00 | 2% 40.56K to 41.56K | (1%) |
| 19-Aug-21 9:04 PM View: | Gwydir Tom Director | Nephros Inc. (NEPH) | 18-Aug-21 | Market Purchase | 5,000 | $7.64 | $38,200.00 | 83% 6.03K to 11.03K | (< 1%) |
| 03-Jun-21 4:41 PM View: | Wexford Capital LLC Director 10% Owner | Nephros Inc. (NEPH) | 01-Jun-21 | Exercise (in-the money or at-the-money) | 66,667 | $2.70 | $180,001.00 | 2% 3.58M to 3.65M | |
| 25-May-21 3:40 PM View: | Evans Daron CEO of Specialty Renal Product | Nephros Inc. (NEPH) | 24-May-21 | Exercise (in-the money or at-the-money) | 2,222 | $2.70 | $5,999.40 | 1% 158.19K to 160.42K | |
| 18-Feb-21 5:48 PM View: | Lobo Wesley S. Chief Marketing Officer | Nephros Inc. (NEPH) | 16-Feb-21 | Grant | 40,557 | -- | -- | 100% 0 to 40.56K | |
| 29-Jan-21 4:49 PM View: | Wexford Capital LLC Director 10% Owner | Nephros Inc. (NEPH) | 27-Jan-21 | Option Exercise | 14,754 | $4.22 | $62,260.40 | 16% 91.28K to 106.04K | |
| 08-Jan-21 5:31 PM View: | Lask Alisa Director | Nephros Inc. (NEPH) | 06-Jan-21 | Grant | 3,666 | -- | -- | 105% 3.48K to 7.14K | |
| 08-Jan-21 5:30 PM View: | Amron Arthur H Director | Nephros Inc. (NEPH) | 06-Jan-21 | Grant | 3,666 | -- | -- | 100% 0 to 3.67K | |
| 08-Jan-21 5:32 PM View: | Gwydir Tom Director | Nephros Inc. (NEPH) | 06-Jan-21 | Grant | 3,666 | -- | -- | 155% 2.37K to 6.03K | |
| 08-Jan-21 5:41 PM View: | Wexford Capital LLC Director 10% Owner | Nephros Inc. (NEPH) | 06-Jan-21 | Grant | 3,196 | -- | -- | 100% 0 to 3.2K | |
| 08-Jan-21 5:31 PM View: | Spandow Oliver J. Director | Nephros Inc. (NEPH) | 06-Jan-21 | Grant | 3,666 | -- | -- | 23% 15.73K to 19.4K | |
| 08-Jan-21 5:31 PM View: | Persen Malcolm C Director | Nephros Inc. (NEPH) | 06-Jan-21 | Grant | 5,921 | -- | -- | 12% 48.05K to 53.97K | |
| 19-Nov-20 6:17 PM View: | Astor Andrew President & CEO Director | Nephros Inc. (NEPH) | 19-Nov-20 | Market Purchase | 1,000 | $5.87 | $5,866.90 | 1% 71.96K to 72.96K | |
| 20-Nov-20 4:28 PM View: | Spandow Oliver J. Director | Nephros Inc. (NEPH) | 18-Nov-20 | Market Purchase | 1,500 | $5.83 | $8,749.20 | 11% 14.23K to 15.73K | |
| 16-Oct-20 4:38 PM View: | Wexford Capital LLC Director 10% Owner | Nephros Inc. (NEPH) | 15-Oct-20 | Grant | 166,667 | $6.00 | $1,000,000.00 | 5% 3.44M to 3.61M | |
| 19-Aug-20 6:22 PM View: | Astor Andrew COO/CFO Director | Nephros Inc. (NEPH) | 19-Aug-20 | Market Purchase | 950 | $7.40 | $7,030.00 | 1% 71.01K to 71.96K | 5% |
| 29-May-20 6:08 PM View: | Astor Andrew CFO/COO | Nephros Inc. (NEPH) | 28-May-20 | Market Purchase | 1,000 | $6.96 | $6,960.00 | 1% 70.01K to 71.01K | 3% |
| 13-May-20 4:56 PM View: | Persen Malcolm C Director | Nephros Inc. (NEPH) | 11-May-20 | Exercise (in-the money or at-the-money) | 1,732 | $7.65 | $13,249.80 | 4% 46.31K to 48.05K | (11%) |
| 12-Mar-20 5:02 PM View: | Evans Daron President and CEO Director | Nephros Inc. (NEPH) | 12-Mar-20 | Market Purchase | 2,500 | $6.65 | $16,625.00 | 2% 155.69K to 158.19K | (1%) |
| 12-Mar-20 4:50 PM View: | Astor Andrew CFO/COO | Nephros Inc. (NEPH) | 12-Mar-20 | Market Purchase | 1,000 | $6.70 | $6,700.00 | 1% 69.01K to 70.01K | (2%) |
| 05-Mar-20 5:18 PM View: | Evans Daron President and CEO Director | Nephros Inc. (NEPH) | 05-Mar-20 | Market Purchase | 2,500 | $8.44 | $21,109.00 | 2% 153.19K to 155.69K | (22%) |
| 05-Mar-20 5:10 PM View: | Astor Andrew CFO/COO | Nephros Inc. (NEPH) | 05-Mar-20 | Market Purchase | 700 | $8.46 | $5,919.69 | 1% 68.31K to 69.01K | (23%) |
| 18-Dec-19 5:12 PM View: | Persen Malcolm C Director | Nephros Inc. (NEPH) | 16-Dec-19 | Grant | 5,437 | -- | -- | 13% 40.88K to 46.31K | |
| 18-Dec-19 5:09 PM View: | Mieyal Paul A Director | Nephros Inc. (NEPH) | 16-Dec-19 | Grant | 3,448 | -- | -- | 100% 0 to 3.45K | |
| 18-Dec-19 5:14 PM View: | Astor Andrew CFO/COO | Nephros Inc. (NEPH) | 16-Dec-19 | Grant | 6,848 | -- | -- | 11% 61.46K to 68.31K | |
| 18-Dec-19 5:14 PM View: | Evans Daron President and CEO Director | Nephros Inc. (NEPH) | 16-Dec-19 | Grant | 9,282 | -- | -- | 6% 143.91K to 153.19K |
